{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:09:23Z","timestamp":1761109763089},"reference-count":123,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.blre.2006.03.001","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T13:22:19Z","timestamp":1150377739000},"page":"267-287","source":"Crossref","is-referenced-by-count":23,"title":["New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies"],"prefix":"10.1016","volume":"20","author":[{"given":"Helen L.","family":"Leather","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Wingard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2006.03.001_bib1","doi-asserted-by":"crossref","unstructured":"EORTC. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group. Am J Med 1989;86:668\u2013672.","DOI":"10.1016\/0002-9343(89)90441-5"},{"key":"10.1016\/j.blre.2006.03.001_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9343(82)90594-0","article-title":"Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia","volume":"72","author":"Pizzo","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.3.CO;2-C","article-title":"Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia. Results of a prospective randomized phase III trial","volume":"83","author":"Kern","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation \u2013 a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib6","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.03.001_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9343(01)01127-5","article-title":"Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy","volume":"112","author":"MacMillan","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2006.03.001_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multi-center trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.03.001_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2141.2005.05727.x","article-title":"Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomized-controlled trials","volume":"131","author":"Vardakas","year":"2005","journal-title":"Br J Haem"},{"key":"10.1016\/j.blre.2006.03.001_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0002-9343(91)90184-Y","article-title":"Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation","volume":"91","author":"Rousey","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000007301","article-title":"Intensive intravenous amphotericin B prophylaxis of systemic fungal infections: results of a prospective controlled pilot study in acute leukemia patients","volume":"46","author":"Karthaus","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1016\/j.blre.2006.03.001_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients","volume":"76","author":"Riley","year":"1994","journal-title":"Am J med"},{"key":"10.1016\/j.blre.2006.03.001_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cncr.11094","article-title":"Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"97","author":"Mattiuzzi","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib18","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (Ambisome) in the prophylaxis of fungal infections in neutropenic patients: a randomized, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0954-6820.1978.tb08410.x","article-title":"Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study","volume":"204","author":"Brincker","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.blre.2006.03.001_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole","volume":"83","author":"Wingard","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.1990.8.2.280","article-title":"Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors","volume":"8","author":"Wiley","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2006.03.001_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1992.tb00945.x","article-title":"Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias","volume":"231","author":"Palmblad","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.blre.2006.03.001_bib24","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archinte.147.4.710","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer. A prospective, randomized, controlled, double-blind study","volume":"147","author":"Hansen","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2006.03.001_bib26","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archinte.144.8.1562","article-title":"Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two","volume":"144","author":"Estey","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2006.03.001_bib27","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.03.001_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2006.03.001_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","article-title":"A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infection in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group","volume":"105","author":"Morgenstern","year":"1999","journal-title":"Br J Haem"},{"key":"10.1016\/j.blre.2006.03.001_bib31","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematologic malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jcp.52.5.376","article-title":"Fluconazole versus itraconazole for the prevention of fungal infections in hemato-oncology","volume":"52","author":"Huijgens","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2006.03.001_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/48.1.97","article-title":"Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients","volume":"48","author":"Boogaerts","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib35","unstructured":"Ullman. Posaconazole (POS) vs Fluconazole (FLU) for Prophylaxis of Invasive Fungal Infections (IFIs) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients With Graft-Versus-Host Disease (GVHD): Results of a Multicenter Trial. In: Program and Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; December 15 \u2013 18th, 2005; Washington DC. Abstract 2111."},{"key":"10.1016\/j.blre.2006.03.001_bib36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.blre.2006.03.001_bib37","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1086\/421953","article-title":"Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation","volume":"39","author":"Wingard","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib38","unstructured":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of the Center for Disease Control and Prevention, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2000;6:659\u2013734."},{"key":"10.1016\/j.blre.2006.03.001_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1703252","article-title":"Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome","volume":"28","author":"Safdar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib40","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/1097-0142(20001001)89:7<1611::AID-CNCR27>3.0.CO;2-B","article-title":"Prophylactic action of oral fluconazole against fungal infection in neutropenic patients: a meta-analysis of 16 randomized, controlled trials","volume":"89","author":"Kanda","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib41","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/cncr.10610","article-title":"Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta-analysis of randomized-controlled clinical trials","volume":"94","author":"Bow","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib42","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib43","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM199110313251814","article-title":"Fluconazole and Candida krusei fungemia","volume":"325","author":"Persons","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib44","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","article-title":"Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients","volume":"37","author":"Wingard","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib45","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1200\/JCO.2003.04.052","article-title":"Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients","volume":"21","author":"Glasmacher","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2006.03.001_bib46","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial","volume":"93","author":"Schwartz","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.03.001_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01697981","article-title":"Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients","volume":"71","author":"Behre","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2006.03.001_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2006.03.001_bib49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"357","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.blre.2006.03.001_bib50","first-page":"41","article-title":"Voriconazole compared with a strategy of amphotericin B followed by fluconazole for treatment of candidemia in non-neutropenic patients","volume":"10","author":"Kullberg","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.blre.2006.03.001_bib51","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.healun.2003.11.206","article-title":"Role of voriconazole prophylaxis for the prevention of invasive aspergillosis (IA) at six months in lung transplant recipients","volume":"23","author":"Husain","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib52","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1473-3099(05)70220-6","article-title":"Zygomycete infection following voriconazole prophylaxis","volume":"5","author":"Van Well","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib53","first-page":"1350","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib55","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib56","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib57","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1086\/427752","article-title":"Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required","volume":"40","author":"Vigouroux","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib58","first-page":"ECR42","article-title":"Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis","volume":"89","author":"Kobayashi","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2006.03.001_bib59","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/427759","article-title":"Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia","volume":"40","author":"Oren","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/00365540410019408","article-title":"Two case reports: fatal Absidia corymbifera pulmonary tract infections in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient","volume":"36","author":"Mattner","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib61","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib63","unstructured":"Park BJ, Kontoyiannis DP, Pappas PG, et al. Comparison of Zygomycosis and Fusariosis to invasive aspergillosis (IA) among transplant recipients reporting to TRANSNET. In: Program and Proceedings of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 30 \u2013 November 2, 2004; Washington DC. Abstract M-666."},{"issue":"Suppl 3","key":"10.1016\/j.blre.2006.03.001_bib64","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1086\/367839","article-title":"Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients","volume":"36","author":"Bennett","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib65","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0959-8049(95)00619-2","article-title":"Fluconazole versus amphotericin B as empiric antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicenter, prospective and randomized clinical trial","volume":"32A","author":"Viscoli","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9343(98)00326-X","article-title":"A randomized comparison of fluconazole with amphotericin B as empirical antifungal agents in cancer patients with prolonged fever and neutropenia","volume":"105","author":"Malik","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empirical antifungal therapy in neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib68","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.1997.2473063.x","article-title":"A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients","volume":"98","author":"Prentice","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.03.001_bib69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/514672","article-title":"Randomized, double-blind clinical trial of amphotericin B colloidal dispersion versus amphotericin B in the empirical treatment of fever and neutropenia","volume":"27","author":"White","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib70","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib71","first-page":"412","article-title":"Intravenous and oral itraconazole versus amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy: a randomized, controlled trial","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib72","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib74","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib75","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1086\/383052","article-title":"Empirical antifungal therapy in treating febrile neutropenic patients","volume":"39","author":"Wingard","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib76","series-title":"Fungal Infections in the Immunocompromised Patient","first-page":"621","author":"Maertens","year":"2005"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2006.03.001_bib77","doi-asserted-by":"crossref","first-page":"LS147","DOI":"10.1080\/13693780500064771","article-title":"The radiological spectrum of pulmonary aspergillosis","volume":"43","author":"Greene","year":"2005","journal-title":"Med Mycol"},{"key":"10.1016\/j.blre.2006.03.001_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computer tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2006.03.001_bib79","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation patients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2006.03.001_bib80","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1086\/343804","article-title":"Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant patients","volume":"186","author":"Maertens","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-0142(20010115)91:2<311::AID-CNCR1003>3.0.CO;2-3","article-title":"Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study","volume":"91","author":"Sulahian","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib82","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease","volume":"34","author":"Boutboul","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib83","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/01.TP.0000120536.20045.AA","article-title":"Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"77","author":"Rovira","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2006.03.001_bib84","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1\u21923)-\u03b2-D-glucan test in weekly screening for invasive aspergillosis in patients with haematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2006.03.001_bib85","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","article-title":"Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients","volume":"20","author":"Herbrecht","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2006.03.001_bib86","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1128\/JCM.41.5.2184-2186.2003","article-title":"Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the platelia test for diagnosing invasive aspergillosis","volume":"41","author":"Pinel","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2006.03.001_bib87","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.2004.05140.x","article-title":"Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients","volume":"126","author":"Maertens","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.03.001_bib88","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/315435","article-title":"Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening","volume":"181","author":"Hebart","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2141.2001.02744.x","article-title":"Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies","volume":"113","author":"Lass-Florl","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.03.001_bib90","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.2000.02378.x","article-title":"Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia","volume":"111","author":"Hebart","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2006.03.001_bib91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"\u03b2-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib92","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) \u03b2-D-Glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichneer","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1\u21923)-\u03b2-D-Glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan","volume":"43","author":"Pazos","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.blre.2006.03.001_bib94","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1086\/323337","article-title":"Use of real-time OCR on blood samples for diagnosis of invasive aspergillosis","volume":"33","author":"Kami","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib95","first-page":"641","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib96","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/444462","article-title":"Galactomannan does not preceded major signs on a pulmonary computerized tomography scan suggestive of invasive aspergillosis in patients with hematological malignancies","volume":"41","author":"Weisser","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib97","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0002-9343(96)80072-6","article-title":"Fluconazole versus amphotericin B in the treatment of hematogenous Candidiasis: a matched cohort study","volume":"101","author":"Anaissie","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib99","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01726360","article-title":"Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group","volume":"16","author":"Phillips","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib100","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib101","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in non-neutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib102","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2006.03.001_bib103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Practice guidelines for the treatment of Candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib104","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"15","author":"Bowden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib105","unstructured":"Smith J, Safdar N, Knasinski V, Andes DR. Voriconazole (V) therapeutic drug monitoring (TDM): Indications, levels, and outcomes at a single tertiary care hospital. In: Program and Proceedings of the 42nd Annual Meeting of the Infectious Disease Society of America; September 30 \u2013 October 3rd, 2004; Boson MA. Abstract 629."},{"key":"10.1016\/j.blre.2006.03.001_bib106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bmt.1704828","article-title":"Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients","volume":"35","author":"Trifilio","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2006.03.001_bib107","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient\u2019s outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.blre.2006.03.001_bib108","unstructured":"Greene R. ECCMID 2003 Abstract."},{"key":"10.1016\/j.blre.2006.03.001_bib109","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.46.1.245-247.2002","article-title":"In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp","volume":"46","author":"Arikan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib111","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/AAC.48.3.970-978.2004","article-title":"In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus","volume":"48","author":"Dannaoui","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib112","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib113","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jac\/dkg242","article-title":"Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus","volume":"51","author":"Manavathu","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib114","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.46.9.3039-3041.2002","article-title":"In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp","volume":"46","author":"Perea","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/AAC.47.4.1452-1455.2003","article-title":"Efficacy of micafungin alone or in combination against systemic murine aspergillosis","volume":"47","author":"Luque","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib116","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1128\/AAC.49.9.3697-3701.2005","article-title":"Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis","volume":"49","author":"MacCallum","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib117","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jac\/dkg425","article-title":"Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin","volume":"52","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.blre.2006.03.001_bib118","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1469-0691.2004.00958.x","article-title":"Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis","volume":"10","author":"Chandresaker","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.blre.2006.03.001_bib119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2006.03.001_bib120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib121","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib122","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/cncr.21057","article-title":"Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis","volume":"103","author":"Kontoyiannis","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2006.03.001_bib123","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X06000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X06000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T14:05:01Z","timestamp":1586959501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X06000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0268960X06000166"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2006.03.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}